These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Increasing stability of antibody via antibody engineering: stability engineering on an anti-hVEGF. Wang S; Liu M; Zeng D; Qiu W; Ma P; Yu Y; Chang H; Sun Z Proteins; 2014 Oct; 82(10):2620-30. PubMed ID: 24916692 [TBL] [Abstract][Full Text] [Related]
12. Rational and systematic protein purification process development: the next generation. Nfor BK; Verhaert PD; van der Wielen LA; Hubbuch J; Ottens M Trends Biotechnol; 2009 Dec; 27(12):673-9. PubMed ID: 19815300 [TBL] [Abstract][Full Text] [Related]
13. Improving solubility and refolding efficiency of human V(H)s by a novel mutational approach. Tanha J; Nguyen TD; Ng A; Ryan S; Ni F; Mackenzie R Protein Eng Des Sel; 2006 Nov; 19(11):503-9. PubMed ID: 16971398 [TBL] [Abstract][Full Text] [Related]
14. Enhancement of scFv fragment reactivity with target antigens in binding assays following mixing with anti-tag monoclonal antibodies. Wang X; Campoli M; Ko E; Luo W; Ferrone S J Immunol Methods; 2004 Nov; 294(1-2):23-35. PubMed ID: 15604013 [TBL] [Abstract][Full Text] [Related]
16. The rapid discovery of engineered antibodies. Wang M; He M IDrugs; 2007 Aug; 10(8):562-5. PubMed ID: 17665332 [TBL] [Abstract][Full Text] [Related]
17. Guided selection of a pan carcinoma specific antibody reveals similar binding characteristics yet structural divergence between the original murine antibody and its human equivalent. Beiboer SH; Reurs A; Roovers RC; Arends JW; Whitelegg NR; Rees AR; Hoogenboom HR J Mol Biol; 2000 Feb; 296(3):833-49. PubMed ID: 10677285 [TBL] [Abstract][Full Text] [Related]
18. Isolation of monoclonal antibody fragments from phage display libraries. Arbabi-Ghahroudi M; Tanha J; MacKenzie R Methods Mol Biol; 2009; 502():341-64. PubMed ID: 19082566 [TBL] [Abstract][Full Text] [Related]
19. Solubility Challenges in High Concentration Monoclonal Antibody Formulations: Relationship with Amino Acid Sequence and Intermolecular Interactions. Pindrus M; Shire SJ; Kelley RF; Demeule B; Wong R; Xu Y; Yadav S Mol Pharm; 2015 Nov; 12(11):3896-907. PubMed ID: 26407030 [TBL] [Abstract][Full Text] [Related]
20. Therapeutic antibody production technologies: molecules, applications, expression and purification. Humphreys DP; Glover DJ Curr Opin Drug Discov Devel; 2001 Mar; 4(2):172-85. PubMed ID: 11378956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]